Mod­er­na to se­cure a UK pres­ence with $1B+ in new man­u­fac­tur­ing and R&D fa­cil­i­ties

As Mod­er­na keeps up the fight against Covid-19, re­cent­ly win­ning au­tho­riza­tion in the US for chil­dren un­der the age of five, the com­pa­ny is al­so look­ing to make a se­ri­ous in­vest­ment in the UK.

Ac­cord­ing to the UK gov­ern­ment, Mod­er­na will be look­ing to es­tab­lish a vac­cine re­search cen­ter and a man­u­fac­tur­ing site for a se­ries of vac­cines.

Mod­er­na will es­tab­lish this new mR­NA In­no­va­tion and Tech­nol­o­gy Cen­tre to de­vel­op mR­NA vac­cines for a wide range of res­pi­ra­to­ry dis­eases, in­clud­ing Covid-19.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN